Skip to main content
Clinical Trials/IRCT20140301016776N3
IRCT20140301016776N3
Not yet recruiting
Phase 2

A randomized, double-blind, placebo-controlled trial evaluating the effect of Morus nigra extract on patients with liver cirrhosis

Mashhad University of Medical Sciences0 sites80 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
iver cirrhosis.
Sponsor
Mashhad University of Medical Sciences
Enrollment
80
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with liver cirrhosis awaiting liver transplantation

Exclusion Criteria

  • Hepatocellular carcinoma or other malignancy
  • History of liver transplantation
  • Alcoholic drink
  • Variceal bleeding
  • Portal vein thrombosis

Outcomes

Primary Outcomes

Not specified

Similar Trials